Stage IV Squamous Cell Carcinoma of the Nasopharynx Terminated Phase 1 Trials for Vorinostat (DB02546)

IndicationStatusPhase
DBCOND0028783 (Stage IV Squamous Cell Carcinoma of the Nasopharynx)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01249443Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV InfectionTreatment